View printer-friendly version
« Back
January 07, 2016 8:00 a.m.
Teva to Present at the 34th Annual J.P. Morgan Healthcare Conference

JERUSALEM--(BUSINESS WIRE)--Jan. 7, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the 34th Annual J.P. Morgan Healthcare Conference. Teva’s management will present on Monday, January 11, 2016 at 10 AM PST.



Teva Presentation at the 34th Annual J.P. Morgan Conference Healthcare Conference


Monday, January 11, 2016 at 10 AM PST




Live over the Internet – log on to the Web at the address above and register for
the event (approximately 10 minutes before). An archive of the webcast will be
available on Teva’s website.


About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit

Source: Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.
United States
Kevin C. Mannix, 215-591-8912
United States
Ran Meir, 215-591-3033
Tomer Amitai, 972 (3) 926-7656
Iris Beck Codner, 972 (3) 926-7687
United States
Denise Bradley, 215-591-8974
United States
Nancy Leone, 215-284-0213